|Date:||23 September 2013|
|Contact:||Press Office 020 3080 7651
Out-of-hours 07770 446 189
Dr Ian Hudson has commenced his appointment as the new Chief Executive of the Medicines and Healthcare Products Regulatory Agency. Dr Hudson replaces former Chief Executive Professor Sir Kent Woods who has stepped down after ten years with the Agency.
Dr Hudson was previously the MHRA’s Director of Licensing for 12 years, responsible for the majority of medicines licensing activities in the UK. This followed a career as a physician, specialising in paediatrics as well as time spent in the pharmaceutical industry working in clinical research and drug development.
The Agency’s Chairman, Sir Gordon Duff said:
"Ian has excellent, broad experience across all aspects of medicines regulation and is ideally placed to lead our Agency, which is unique in bringing together medicines and medical devices regulation together with world-class research facilities and expertise."
Dr Hudson said:
"I’m delighted to be appointed to the role of Chief Executive. The Agency plays a critical role in ensuring that medicines and medical devices help people and are acceptably safe; we support research and development; and protect and promote the health of millions of people through our activities.
"Sir Kent has led the Agency very effectively and has developed it into one of the leading medicines and medical devices regulators in the world. I am proud to have been selected to succeed him."
Notes to Editor1. Professor Sir Kent Woods worked as a physician in the NHS for 30 years before taking up the post of Chief Executive at the Medicines and Healthcare products Regulatory Agency in January 2004, having been Director of the NHS Health Technology Assessment Programme from 1999 to 2003. He trained at Cambridge, Birmingham and Harvard School of Public Health and held a personal chair in Therapeutics at Leicester University until the end of May 2013. Professor Sir Kent Woods will continue as Chair of the Management Board of the European Medicines Agency.
2. The Medicines and Healthcare Products Regulatory Agency is responsible for protecting and improving the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. The Agency consists of three centres: the Clinical Practice Research Datalink (CPRD), the National Institute for Biological Standards and Control (NIBSC) and the MHRA.